Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Montorsi

Showing results (201-210 of 2,970) with videos related to

Pageof 297
Sort By:
Asian Journal of Andrology|November 23, 2016
Sexual dysfunction and prostate cancer risk: one more piece of a complex puzzlePaolo Capogrosso, Francesco Montorsi, Andrea Salonia
Physical Review Letters|April 2, 2019
Interaction-Induced Fractionalization and Topological Superconductivity in the Polar Molecules Anisotropic t-J ModelSerena Fazzini, Luca Barbiero, Arianna Montorsi
European Urology|July 23, 2019
Surgical Safety of Cytoreductive Nephrectomy Following Systemic Therapy: What Should We Look For?Umberto Capitanio, Francesco Montorsi, Alessandro Larcher
Lymphology|September 1, 1983
Experimental lymphatico-venous shunt in the rat: pressure controls and long-term patencyU Fox, M Montorsi, G Romagnoli
European Urology|March 25, 2015
Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9Firas Abdollah, Francesco Montorsi, Alberto Briganti
The Lancet. Oncology|July 4, 2012
Focal HIFU for prostate cancerMassimo Lazzeri, Giorgio Guazzoni, Francesco Montorsi
European Urology Oncology|April 8, 2023
Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505-16Francesco Montorsi, Marco Moschini, Alberto Briganti
European Urology|August 18, 2020
Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti
BJU International|August 18, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancerFrancesco Montorsi, Marco Moschini, Andrea Necchi
Current Medical Research and Opinion|July 5, 2003
Sildenafil in erectile dysfunction: a critical reviewAndrea Salonia, Patrizio Rigatti, Francesco Montorsi
Pageof 297

Showing results (201-210 of 2,970) with videos related to

Sort By:
Pageof 297
Asian Journal of Andrology|November 23, 2016
Sexual dysfunction and prostate cancer risk: one more piece of a complex puzzlePaolo Capogrosso, Francesco Montorsi, Andrea Salonia
Physical Review Letters|April 2, 2019
Interaction-Induced Fractionalization and Topological Superconductivity in the Polar Molecules Anisotropic t-J ModelSerena Fazzini, Luca Barbiero, Arianna Montorsi
European Urology|July 23, 2019
Surgical Safety of Cytoreductive Nephrectomy Following Systemic Therapy: What Should We Look For?Umberto Capitanio, Francesco Montorsi, Alessandro Larcher
Lymphology|September 1, 1983
Experimental lymphatico-venous shunt in the rat: pressure controls and long-term patencyU Fox, M Montorsi, G Romagnoli
European Urology|March 25, 2015
Reply to Jovo Bogdanović and Vuk Sekulić's Letter to the Editor re: Firas Abdollah, Giorgio Gandaglia, Nazareno Suardi, et al. More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer. Eur Urol 2015;67:212-9Firas Abdollah, Francesco Montorsi, Alberto Briganti
The Lancet. Oncology|July 4, 2012
Focal HIFU for prostate cancerMassimo Lazzeri, Giorgio Guazzoni, Francesco Montorsi
European Urology Oncology|April 8, 2023
Re: Wei Shan Tan, Gary Steinberg, J. Alfred Witjes, et al. Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group. Eur Urol Oncol 2022;5:505-16Francesco Montorsi, Marco Moschini, Alberto Briganti
European Urology|August 18, 2020
Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti
BJU International|August 18, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancerFrancesco Montorsi, Marco Moschini, Andrea Necchi
Current Medical Research and Opinion|July 5, 2003
Sildenafil in erectile dysfunction: a critical reviewAndrea Salonia, Patrizio Rigatti, Francesco Montorsi
Pageof 297